Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study

✍ Scribed by Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H. Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E. Kjeldsen; Lars H. Lindholm; Markku S. Nieminen; Richard B. Devereux

• Book ID: 119264700
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 133 KB
• Volume: 45
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/j.jacc.2004.10.068